- HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
-
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
- -
-
Page/Page column 111; 112
(2015/11/09)
-
- PROCESS FOR PREPARING TRIAZOLONES
-
The present process provides a improved method for the preparation of alkylsulfanyl substituted triazoles 2 which are useful intermediates in a new process for the preparation of triazolones
- -
-
Page/Page column 18
(2009/01/20)
-
- Heterocyclic antiviral compounds
-
The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula I where R1, R2, R3, R4, R5, are as defined herein.
- -
-
Page/Page column 12
(2010/02/15)
-
- Non-nucleoside reverse transcriptase inhibitors
-
The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R7a, R7b, R7c, R8-R10, X1, X2 m, n, o and p are as defined herein.
- -
-
Page/Page column 39
(2008/06/13)
-
- Substituted imidazol-pyridazine derivatives
-
The present invention relates to compounds of formula wherein A is an unsubstituted or substituted cyclic group; and R is hydrogen or lower alkyl; or a pharmaceutically acceptable acid addition salt thereof. These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.
- -
-
-
